Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 162.08%11.16M | 139.30%6.51M | -156.36%-30.99M | -208.24%-80.59M | -113.95%-17.97M | -741.60%-16.56M | -1,795.47%-12.09M | -12,774.13%-26.15M | -18,668.19%-15.14M | -19,121.05%-8.4M |
| Net income from continuing operations | 91.30%-2.39M | 117.54%4.04M | 29.64%-10.67M | -256.20%-115.79M | -140.81%-27.41M | -1,017.35%-23M | -649.52%-15.16M | -16,803.34%-32.51M | -23,906.86%-17.04M | -28,055.60%-11.38M |
| Operating gains losses | 612.53%1.92M | -3,277.34%-4.07M | -170.00%-7K | 763.81%2.09M | ---375K | --128K | --10K | --241.61K | --23.56K | ---- |
| Depreciation and amortization | 119.62%806K | 23.63%450K | -89.69%33K | 572.01%1.68M | --367K | --364K | --320K | --250.4K | --250.4K | --0 |
| Unrealized gains and losses of investment securities | 221.74%8.23M | 103.28%3.47M | --6.37M | --6.49M | --2.56M | --1.71M | --0 | --0 | --0 | --0 |
| Remuneration paid in stock | -55.04%758K | -11.81%1.51M | 209.18%1.99M | 50.24%5.44M | 66.34%1.69M | 2,055.83%1.71M | -57.98%643K | --3.62M | --999.64K | --1.01M |
| Other non cashItems | -111.28%-213K | -80.20%497K | -214.06%-219K | 1,940.07%5.49M | --1.89M | --2.51M | --192K | --268.98K | --133.56K | ---- |
| Change In working capital | -38.33%2.04M | 2,552.17%610K | -1,594.70%-28.49M | 608.49%14.01M | 105.13%3.31M | 93.24%23K | 1,411.16%1.91M | 18,446.56%1.98M | 5,221.79%495.64K | 49,384.07%1.62M |
| -Change in receivables | 36.95%-476K | 1,413.22%2.29M | -977.66%-2.48M | 18.83%-101.68K | -1,711.25%-755K | 8.57%-174K | 161.02%282K | -1,013.39%-125.27K | 88.18%-1.31K | -5,058.91%-41.68K |
| -Change in inventory | 1,098.04%3.57M | -2,748.00%-1.42M | -6,295.20%-7.99M | -165.60%-929.66K | ---358K | ---50K | ---125K | ---350.03K | ---350.03K | --0 |
| -Change in prepaid assets | -16.23%-616K | -189.37%-437K | -93.28%16K | ---- | -80.41%-530K | 707.22%489K | 2,835.01%238K | ---- | ---- | ---293.77K |
| -Change in payables and accrued expense | -108.84%-438K | 176.86%186K | -1,293.65%-18.04M | 513.24%15.04M | 154.09%4.96M | -185.59%-242K | 677.79%1.51M | 517,305.49%2.45M | 33,357.41%480.78K | 79,099.35%1.95M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 162.08%11.16M | 139.30%6.51M | -156.36%-30.99M | -208.24%-80.59M | -113.95%-17.97M | -741.60%-16.56M | -1,795.47%-12.09M | -12,774.13%-26.15M | -18,668.19%-15.14M | -19,121.05%-8.4M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -573.24%-21.03M | -1,351.86%-18.7M | -40,823.08%-15.96M | -63.30%-7.17M | 57.91%-3.12M | -322.17%-1.29M | -101.16%-39K | -2,438.89%-4.39M | 88.75%-19.46K | -7.42M |
| Net PPE purchase and sale | ---- | -1,351.86%-18.7M | -40,823.08%-15.96M | -3,471.43%-7.17M | 58.27%-3.11M | ---1.29M | ---39K | ---200.85K | --7.26M | ---7.46M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---4.19M | ---7.35M | --2K |
| Net other investing changes | ---- | ---- | ---- | ---- | -100.42%-156 | ---- | ---- | ---- | ---- | --36.73K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -573.24%-21.03M | -1,351.86%-18.7M | -40,823.08%-15.96M | -63.30%-7.17M | 57.91%-3.12M | -322.17%-1.29M | -101.16%-39K | -2,438.89%-4.39M | 88.75%-19.46K | ---7.42M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4,589.75%31.97M | -71.38%17.66M | 8,624.70%28.3M | 139.67%108.35M | -102.34%-712K | 29,281.90%61.7M | -332K | 45.21M | 14.55M | 30.45M |
| Net issuance payments of debt | -194.08%-1.04M | -49.32%16.52M | 1,611.88%10.05M | 53,247.07%52.56M | ---355K | --32.59M | ---665K | ---98.89K | ---98.89K | --0 |
| Net common stock issuance | --40.65M | --0 | --20.05M | 29.51%61.75M | --0 | --33M | --0 | --47.68M | --17.02M | --30.45M |
| Cash dividends paid | --0 | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | 138.22%2.16M | 6.32%1.92M | 20.77%471K | 838.22%6.64M | --908K | --1.81M | --390K | --707.5K | --707.5K | --0 |
| Interest paid (cash flow from financing activities) | -589.26%-7.13M | ---- | ---- | ---3.5M | ---1.03M | ---- | ---- | --0 | --0 | ---- |
| Net other financing activities | -1,058.44%-2.68M | 85.92%-774K | -3,892.98%-2.28M | -195.13%-9.1M | ---231K | ---5.5M | ---57K | ---3.08M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 4,589.75%31.97M | -71.38%17.66M | 8,624.70%28.3M | 139.67%108.35M | -102.31%-712K | 29,481.90%61.7M | ---332K | --45.21M | --14.55M | --30.87M |
| Net cash flow | ||||||||||
| Beginning cash position | -50.32%23.7M | 373.70%18.23M | 126.13%36.88M | 893.70%16.31M | 1,978.89%47.7M | -11.69%3.85M | 893.71%16.31M | -18.64%1.64M | 792.92%16.92M | 18.37%2.29M |
| Current changes in cash | 201.30%22.09M | -87.53%5.47M | -49.68%-18.65M | 40.31%20.58M | -249.11%-21.81M | 2,226.38%43.86M | -558.81%-12.46M | 3,999.91%14.67M | -140.95%-611.24K | 33,564.71%14.63M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---9.58K | --81.95K | ---- | ---- | --0 | --0 | --0 |
| End cash Position | 76.82%45.79M | -50.32%23.7M | 373.70%18.23M | 126.13%36.88M | 53.05%25.9M | 1,978.89%47.7M | -11.69%3.85M | 893.70%16.31M | 893.70%16.31M | 792.92%16.92M |
| Free cash from | 53.19%-9.88M | 31.68%-12.19M | -287.12%-46.95M | -233.12%-87.77M | -33.01%-21.1M | -807.07%-17.85M | -1,801.59%-12.13M | -12,873.03%-26.35M | -9,668.62%-7.88M | -36,191.83%-15.86M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.